Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...
News-Medical.Net on MSN6h
New drug target identified for treating acute myeloid leukemiaA team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...
When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, ...
Almost two years after being diagnosed with Stage 3, Group 3 Rhabdomyosarcoma, Philipsburg’s C.J. Coudriet is giving back to ...
This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...
A nationwide team led by researchers at Baylor College of Medicine, Texas Children's Hospital and UPMC Children's Hospital of ...
Hemogenyx Pharmaceuticals Files Annual IND Report with FDA for HG-CT-1 CAR-T Therapy for AML LONDON, UK / ACCESS Newswire / April 3, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to annou ...
News Medical on MSN15h
Breakthrough study links NSD2 gene to plasma cell identity in myelomaA new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback